This grant will fund research to improve clinical trial readiness for rare diseases by developing tools like biomarkers and outcome measures to help move new treatments or diagnostics toward successful trials.
This grant funds research to develop and optimize new devices for brain and addiction disorders, supporting their progress toward readiness for initial human trials.
This grant funds further development and validation of new molecular and cellular analysis technologies to improve basic and clinical cancer research, excluding projects using existing technologies for new targets.
This grant funds innovative research to develop or improve broadly applicable models, materials, and methodologies for studying multiple body systems or diseases relevant to human health, excluding single disease or system studies.
NIDA plans to fund research developing interventions to prevent and treat substance use disorders and overdoses, from preclinical studies to clinical trials.